Literature DB >> 16621878

Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.

A Phrommintikul1, A Sukonthasarn, R Kanjanavanit, W Nawarawong.   

Abstract

OBJECTIVE: To determine the association between splenectomy and pulmonary hypertension in patients with thalassaemia with anaemia.
DESIGN: Prospective cross-sectional study.
METHODS: 68 patients with thalassaemia, who had a haemoglobin concentration of less than 100 g/l, were recruited into this study. Echocardiography was performed before clinical data were reviewed. Pulmonary artery pressure was estimated by measuring the systolic transtricuspid pressure gradient from tricuspid regurgitation and adding it to the right atrial pressure, which was estimated by the response of the inferior vena cava to inspiration. Pulmonary hypertension was defined as systolic pulmonary artery pressure > 35 mm Hg. History of splenectomy and other clinical data were compared between patients with and without pulmonary hypertension.
RESULTS: 29 patients had pulmonary hypertension and 39 did not. Patients with pulmonary hypertension had significantly more nucleated red blood cells and higher platelet counts, and a higher prevalence of splenectomy (75.8% v 25.6%, odds ratio 9.1, 95% confidence interval 3.0 to 27.7). In multivariate analysis, splenectomy was the only factor significantly related to pulmonary hypertension.
CONCLUSION: Splenectomy is a strong risk factor for pulmonary hypertension in patients with thalassaemia.

Entities:  

Mesh:

Year:  2006        PMID: 16621878      PMCID: PMC1861039          DOI: 10.1136/hrt.2005.079970

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  32 in total

1.  Pulmonary hypertension in patients with thalassemia major.

Authors:  Z D Du; N Roguin; E Milgram; K Saab; A Koren
Journal:  Am Heart J       Date:  1997-09       Impact factor: 4.749

2.  Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes.

Authors:  F Mannu; P Arese; M D Cappellini; G Fiorelli; M Cappadoro; G Giribaldi; F Turrini
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

3.  Enhanced aggregability of red blood cells of beta-thalassemia major patients.

Authors:  S Chen; A Eldor; G Barshtein; S Zhang; A Goldfarb; E Rachmilewitz; S Yedgar
Journal:  Am J Physiol       Date:  1996-06

4.  Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.

Authors:  Athanasios Aessopos; Dimitrios Farmakis; Spyros Deftereos; Maria Tsironi; Stergios Tassiopoulos; Ioannis Moyssakis; Markisia Karagiorga
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

5.  In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major.

Authors:  A Ruf; M Pick; V Deutsch; H Patscheke; A Goldfarb; E A Rachmilewitz; M C Guillin; A Eldor
Journal:  Br J Haematol       Date:  1997-07       Impact factor: 6.998

6.  Left ventricular diastolic Doppler characteristics in beta-thalassemia major.

Authors:  D T Kremastinos; D P Tsiapras; G A Tsetsos; E I Rentoukas; H P Vretou; P K Toutouzas
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Indices of membrane alterations in beta-thalassemic erythrocytes.

Authors:  D Tavazzi; A Comino; F Turrini; G Fiorelli; M D Cappellini
Journal:  Hemoglobin       Date:  1998 Sep-Nov       Impact factor: 0.849

8.  Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.

Authors:  A Aessopos; G Stamatelos; V Skoumas; G Vassilopoulos; M Mantzourani; D Loukopoulos
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

9.  Oxidative status of platelets in normal and thalassemic blood.

Authors:  Johnny Amer; Eitan Fibach
Journal:  Thromb Haemost       Date:  2004-11       Impact factor: 5.249

10.  Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia.

Authors:  M D Cappellini; D Tavazzi; L Duca; G Graziadei; F Mannu; F Turrini; P Arese; G Fiorelli
Journal:  Br J Haematol       Date:  1999-03       Impact factor: 6.998

View more
  21 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report.

Authors:  Simona Roggero; Silvia Vullo; Gisella Volpe; Antonio Piga; Carlo Albera
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

3.  Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.

Authors:  Claudia R Morris; Hae-Young Kim; Felicia Trachtenberg; John Wood; Charles T Quinn; Nancy Sweeters; Janet L Kwiatkowski; Alexis A Thompson; Patricia J Giardina; Jeanne Boudreaux; Nancy F Olivieri; John B Porter; Ellis J Neufeld; Elliott P Vichinsky
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

4.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

5.  Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension.

Authors:  Claudia R Morris; Hae-Young Kim; John Wood; John B Porter; Elizabeth S Klings; Felicia L Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Sylvia T Singer; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Vandana Sachdev; Sandra Larkin; Jung H Suh; Frans A Kuypers; Elliott P Vichinsky
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 6.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 7.  Pulmonary hypertension associated with thalassemia syndromes.

Authors:  Dustin R Fraidenburg; Roberto F Machado
Journal:  Ann N Y Acad Sci       Date:  2016-03-23       Impact factor: 5.691

8.  Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.

Authors:  Casey J Brewer; Thomas D Coates; John C Wood
Journal:  J Magn Reson Imaging       Date:  2009-02       Impact factor: 4.813

9.  Platelets in pulmonary hypertension: a causative role or a simple association?

Authors:  Keyhan Sayadpour Zanjani
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

Review 10.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.